Literature DB >> 27643907

HIV-Associated Neurologic Disorders and Central Nervous System Opportunistic Infections in HIV.

Leah T Le1, Serena S Spudich1.   

Abstract

Since the advent of combination antiretroviral therapy (cART), HIV has transformed from a fatal disease to a chronic illness that often presents with milder central nervous system (CNS) symptoms laced with related confounders. The immune recovery associated with access to cART has led to a new spectrum of immune-mediated presentations of infection, phenotypically distinct from the conditions observed in advanced disease.HIV-associated neurocognitive disorder (HAND) entails a categorized continuum of disorders reflecting an array of clinical presentation, outcome, and increasing level of severity: asymptomatic neurocognitive impairment (ANI), mild neurocognitive disorder (MND), and HIV-associated dementia (HAD). HAND is defined through an assessment of neurocognitive abilities and functional performance. Progressive neurologic symptoms detected in patients on cART with detectable CSF viral load and a suppressed plasma viral load, or CSF viral load 1 log10 greater than low detectable plasma viral load, characterize a phenomenon termed symptomatic CSF "escape." CD8+ T-cell encephalitis, possibly a form of CNS immune reconstitution inflammatory syndrome, resembles CNS "escape" as it presents in patients despite viral suppression with cART. Cerebral toxoplasmosis, cryptococcal meningitis, and progressive multifocal leukoencephalopathy, are AIDS defining conditions with associated high mortality risk. Cerebral toxoplasmosis and cryptococcal meningitis typically manifest in immunosuppressed patients (<200 CD4+ T-cells/μL), while PML can occur in patients with higher CD4+ T-cell counts.Neurologic conditions are increasingly interconnected with chronic diseases, and classic opportunistic infections may have altered phenotypes in the cART era. However, there exist promising diagnostic methods and therapeutic approaches, as well as associated pitfalls in diagnosis and treatment. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 27643907     DOI: 10.1055/s-0036-1585454

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  12 in total

1.  Psychosis of dual origin in HIV infection: Viral escape syndrome and autoimmune encephalitis.

Authors:  David Anguizola-Tamayo; Jone Bocos-Portillo; Lara Pardina-Vilella; Aida Rodriguez-Sainz; Iñigo Vicente-Olabarria; Eduardo Martínez; Marian Gomez-Beldarrain; Juan Carlos Garcia-Monco
Journal:  Neurol Clin Pract       Date:  2019-04

2.  The EGF epidermal growth factor counteracts Tat modulation of human endogenous retroviruses of the W family in astrocytes.

Authors:  Elena Uleri; Claudia Piu; Maurizio Caocci; Gabriele Ibba; Caterina Serra; Antonina Dolei
Journal:  J Neurovirol       Date:  2017-05-04       Impact factor: 2.643

3.  Toxoplasma gondii infection in hospitalized people living with HIV in Spain, 1997 to 2015.

Authors:  Marouane Menchi-Elanzi; Asunción M Mayoral; Javier Morales; Hector Pinargote-Celorio; Gregorio González-Alcaide; José-Manuel Ramos-Rincón
Journal:  Parasitol Res       Date:  2021-01-14       Impact factor: 2.289

4.  Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.

Authors:  Lucette A Cysique; Bruce J Brew
Journal:  J Neurovirol       Date:  2019-01-11       Impact factor: 2.643

Review 5.  HIV-Proteins-Associated CNS Neurotoxicity, Their Mediators, and Alternative Treatments.

Authors:  Adonira Saro; Zhaolin Gao; Piniel Alphayo Kambey; Paul Pielnaa; Dama Faniriantsoa Henrio Marcellin; Aixiang Luo; Ruping Zheng; Zhongjun Huang; Lvshuang Liao; Mingxuan Zhao; Liangpeng Suo; Shuang Lu; Min Li; Deyang Cai; Dan Chen; Haiyang Yu; Jufang Huang
Journal:  Cell Mol Neurobiol       Date:  2021-09-25       Impact factor: 4.231

6.  Co-infection of human immunodeficiency virus, herpes simplex virus-2 and SARS-CoV-2 in a patient with false-negative real-time polymerase chain reaction results.

Authors:  Abdulrahman Alharthy; Fahad Faqihi; AlFateh Noor; Ziad A Memish; Dimitrios Karakitsos
Journal:  Singapore Med J       Date:  2020-11-30       Impact factor: 3.331

Review 7.  Neuroimmunology of CNS HIV Infection: A Narrative Review.

Authors:  Ana-Claire Meyer; Alfred Kongnyu Njamnshi; Magnus Gisslen; Richard W Price
Journal:  Front Neurol       Date:  2022-06-14       Impact factor: 4.086

8.  HIV influences microtubule associated protein-2: potential marker of HIV-associated neurocognitive disorders.

Authors:  Valeria Avdoshina; Matthew Mahoney; Sean F Gilmore; Erin D Wenzel; Albert Anderson; Scott L Letendre; Tomozumi Imamichi; Nicholas O Fischer; Italo Mocchetti
Journal:  AIDS       Date:  2020-06-01       Impact factor: 4.632

Review 9.  HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease.

Authors:  José Ernesto Vidal
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

10.  CD8 encephalitis with CSF EBV viraemia and HIV drug resistance, a case series.

Authors:  C Kerr; H Adle-Biassette; P B Moloney; S Hutchinson; J B Cryan; S Clarke; F Mulcahy; E Devitt
Journal:  Brain Behav Immun Health       Date:  2020-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.